Notable is harnessing our predictive medicine platform to build a pipeline of novel therapeutics. By matching the right drug with the right patient, we aim to increase the clinical response rate of the therapeutics in our pipeline while reducing the risk, time and cost of development. #biopharma, #biopharmaceuticals, #therapeutics, #cancer, #AML, #flowcytometry, #roboticautomation, #pipeline
Notable’s Post
More Relevant Posts
-
Cantargia AB's Nadunolimab, a novel IL1RAP-targeting antibody, shows promising efficacy in PDAC treatment with reduced neuropathic side effects when combined with chemotherapy, as demonstrated in the CANFOUR trial. Nadunolimab is a fully humanized monoclonal IgG1 antibody targeting the IL1 receptor accessory protein (IL1RAP). By binding to IL1RAP, nadunolimab induces antibody-dependent cellular cytotoxicity (ADCC) of IL1RAP-expressing tumor cells and inhibits tumor-promoting signals mediated by IL-1α and IL-1β within the tumor microenvironment. Benefit from Expert Insights and Extensive Analysis with DelveInsight Business Research LLP's ASCO 2024 Exclusive Coverage: https://lnkd.in/gDHfK75D #ASCO24 #CancerTreatment #ASCO2024 #LungCancer #NSCLC #mCRPC #PharmaInnovation #MedicalResearch #OncologyAdvancements #ClinicalOncology #Pharmaceuticals #HealthcareConference #CancerResearch #ClinicalPractice #MedicalBreakthroughs #CancerCare #PharmaLeaders
-
HRW Patient Panorama, our patient research team, recently worked with a client to develop a comprehensive portfolio in the bladder cancer space. The team conducted foundational research with bladder cancer patients to identify unmet needs and pain points across the patient journey to develop communications and valued added services to optimise opportunities for their portfolio of products. Check out our latest case study to read more about the teams findings. #patientresearch #patientjourney #bladdercancer #cancer #oncology #oncologist #communications #products #opportunities #portfolio #marketresearch #MRX #healthcaremarketresearch #healthcare #health #pharma #pharmaceuticalresearch #pharmaceutical #carousel #casestudy
-
On Prostate Cancer Awareness Day, we emphasize the role of innovation in healthcare. Advancing diagnostics and therapies is key to early detection and effective treatment. Let’s drive progress together for a healthier tomorrow. #ProstateCancerAwareness #pharmaceutical #parsianpharma #prostatecancer #cancer #oncology #olaparib #abiraterone #API #granule
-
-
Principal Research Scientist and Team Leader at Vertex Pharmaceuticals | C&EN Talented 12 | J.Med.Chem Editorial Advisory Board
Pick of the week from J Med Chem: covalent Bfl-1 inhibitors from AstraZeneca (Simon Lucas) for oncology indications. A covalent strategy to maximize selectivity within protein family and to gain potency in a more efficient way (lower MW, better LipE) than previous PPI inhibitors cases. The structure-based optimization effort was fueled by findings in MS and X-Ray screenings to deliver cell-active compounds #medchem https://lnkd.in/eeudWpC9
Structure-Based Optimization of a Series of Covalent, Cell Active Bfl-1 Inhibitors
pubs.acs.org
-
Senior Human Resources Leader │ Servant Leader │ Total Rewards │ Benefits │ Compensation │ Engagement │ HRIS │ HR Operations │ International Mobility │ Diversity & Inclusion │ National │ Regional │ Global
From early detection to understanding resistance mechanisms, biomarkers can play a crucial role in personalizing oncology treatment plans. To learn more about the utility of biomarkers for your hematology drug development program, speak with our oncology experts at #ESMO24: https://bit.ly/4eaLBdK
-
-
From early detection to understanding resistance mechanisms, biomarkers can play a crucial role in personalizing oncology treatment plans. To learn more about the utility of biomarkers for your hematology drug development program, speak with our oncology experts at #ESMO24: https://bit.ly/4d7vUmG
-
-
Pharma Industry Updates 1. Capra Biosciences's $75M Boost for US APIs, a significant investment to enhance API manufacturing and innovation. 💸 2. Nanoparticles revolutionize abdominal aortic aneurysms (AAA) treatment, offering new hope for abdominal aortic aneurysm patients. 🔬 3. Shuttle Pharmaceuticals, Inc.'s HDAC Inhibitor for Breast Cancer, showing potential in advanced treatment options. 🧬 4. #Opdivo & #Yervoy promising for advanced HCC treatment, a breakthrough in liver cancer therapy. 🩺 💬 Join the Conversation! Which breakthrough excites you the most? Let us know in the comments! 🗣️ 🔗 Read more news- https://lnkd.in/dh36nZ8Y 🔗 Stay tuned for more pharma updates and insights! #pharmanews #healthcareinnovation #cancerresearch #API #nanotechnology #pharmaupdates #pharmanow
-
Senior Human Resources Leader │ Servant Leader │ Total Rewards │ Benefits │ Compensation │ Engagement │ HRIS │ HR Operations │ International Mobility │ Diversity & Inclusion │ National │ Regional │ Global
From early detection to understanding resistance mechanisms, biomarkers can play a crucial role in personalizing oncology treatment plans. To learn more about the utility of biomarkers for your hematology drug development program, speak with our oncology experts at #ESMO24: https://bit.ly/3AJD0jL
-
-
Biotech M.S. grad | Eurofins Advinus | Discovery Services | Innovation and strategic collaboration | Let's connect! #Happy_Analysing 🌐
🔬 As biotechnologists, we often rely on antibodies to characterize various biological properties and phenotypes in our daily work. However, delving into the characterization of therapeutic antibodies can provide valuable insights that enhance our understanding and drive innovation. Let's continue to explore the potential of these powerful concept! #Biotech #AntibodyResearch #Innovation #DrugDiscovery #Therapeutics
How do you comprehensively characterize therapeutic antibodies? Don’t miss out on this case study demonstrating our molecular approach to thoroughly characterize trastuzumab, a humanized monoclonal antibody targeted against the ErbB2 protein and approved to treat HER2-positive breast cancer. This case study highlights guidelines from regulatory agencies regarding monoclonal antibodies. It shows how the Eurofins Discovery approach provides you with the robust, reliable, and quality data you need to make confident decisions that will progress your program into preclinical development. Download now to see how Eurofins Discovery’s safety screening and profiling vigilance can save you time and resources in your biotherapeutics program. Get more details: https://lnkd.in/gnNk_7VQ #biotherapeutics #trastuzumab #drugdiscovery #eurofinsdiscovery
-
At Cliantha, we specialize in conducting clinical studies for new chemical entities (NCEs) in oncology. Our expertise encompasses the design, execution, and analysis of trials aimed at evaluating novel treatments for cancer, ensuring rigorous assessment and advancement of promising therapies. To learn more, write to us: info@cliantha.com. #earlyphase #latephase #phase1 #phase2 #phase3 #phase4 #pharmaceuticals #drug #clinicaltrials #clinicalstudies #clinicalresearch #research #oncology #lymphoma #lungcancer #ovariancancer #renalcancer #colorectalcancer
-
All the ingredients for success for patients, clinicians, and investors are coming together at Notable. At biomedwoRx: Life Sciences Consulting, we're proud to support these advances!